Pharma major, Aurobindo Pharma has received Form 483 with 2 observations from the USFDA, reported a leading business daily.
The stock of Aurobindo Pharma was trading flat during Wednesday's trade on the BSE. The stock was trading at Rs 705 per share, down by Rs 3.50 or 0.49% as at 1010 hours on Wednesday, on the BSE. The stock hit an intraday high and low of Rs 712.50 and Rs 703.60, respectively. It had witnessed a spurt in volume by more than 4.56 times during Tuesday’s trade.
The stock attracted a traded volume of 3,02,050 shares and traded value of Rs 2,137.97 lakh on the NSE. The company had hit its 52-week high of Rs 895 on October 6, 2016, and 52-week low of Rs 503.05 on May 29, 2017, on the NSE.
Aurobindo Pharma Limited is a pharmaceutical company. The company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs).
Looking for investment in Share Market, CapitalStars Financial Research Private Limited provides you best investments Tips in Share Market.It daily provides intraday and Future calls.We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities.
Get more details here:-
* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
0 comments:
Post a Comment